May 27, 2020 — U.S. District Judge Jane Triche Milazzo dismissed nearly 200 lawsuits by patients, saying the change in the drug’s warning label in 2015 clearly explained its risks. She ruled that the updated Taxotere label was legally adequate as it warned about the risk of the permanent hair loss patients suffered. Judge Milazzo explained that the label...
Continue ReadingMay 5, 2020 — “The Court reset the second bellwether trial for October 19, 2020.” Reference: “United States District Court.” MDL – 2740 Taxotere (Docetaxel) Products Liability Litigation | Eastern District of Louisiana | United States District Court, 28 Dec. 2020, www.laed.uscourts.gov/case-information/mdl-mass-class-action/taxotere
Continue ReadingApril 1, 2020 — On April 1, 2020, the FDA ordered the removal of all ranitidine products from the market. Reference: “FDA Requests Removal of All Ranitidine Products (Zantac) from the Market.” U.S. Food and Drug Administration, FDA, www.fda.gov/news-events/press-announcements/fda-requests-removal-all-ranitidine-products-zantac-market.
Continue ReadingApril 2, 2020 — On April 2, 2020, Judge Rosenberg ordered a 2 part census of Zantac claims in Pretrial Order #15. The first part of the census was meant to relay how many cases are in MDL 2924. The second part was meant to relay what the allegations of Zantac use and damages are, requiring information from attorneys...
Continue ReadingMarch 2020 — Sanofi said it faced lawsuits by 10,628 plaintiffs in federal court as well as state courts in New Jersey, California, and Delaware in March 2020. Reference: Raymond, Nate. “Warning Label Change for Sanofi’s Taxotere Dooms 200 Hair Loss Cases – Judge.” Reuters, Thomson Reuters, 28 May 2020, www.reuters.com/article/products-taxotere/warning-label-change-for-sanofis-taxotere-dooms-200-hair-loss-cases-judge-idUSL1N2DA1ZO
Continue ReadingFebruary 17, 2020 – Sanofi has taken a $186 million write-off for Zantac after recalling it back in October 2019. The following companies have now recalled a version of Zantac: Sanofi Golden State Medical Supply Novitium Pharma Amneal Northwind Pharmaceuticals (a.k.a. Denton Pharma) Sandoz (pharma division of Novartis) Appco Pharma Apotex Perrigo Lannett Company Aurobindo Also, Walgreens and CVS have...
Continue ReadingEisai Inc. voluntarily pulled Belviq from the market after the FDA said the drug poses the risk of causing breast cancer. Belviq is a weight loss drug, and a recent FDA study shows that 7.7% of users developed cancer. Eisai Inc. said, while it pulled the product from the market voluntarily, it disagrees with the FDA’s analysis of the...
Continue ReadingFebruary 6, 2020 — On February 6, 2020, the Judicial Panel on Multidistrict Litigation transferred over 140 Zantac lawsuits to Judge Robin Rosenberg in Miami under MDL No. 2924. Since then, over 400 additional cases have joined MDL 2924. Judge Rosenberg had not previously handled an MDL and was appointed by President Obama. References: Rosenberg, Judge Robin. In Re...
Continue ReadingJanuary 29, 2020 – New lawsuits are emerging as the public learns more about the alleged adverse effects of taking Zantac. Victims are now claiming it has caused stomach cancer, colon cancer, and even leukemia. These are in addition to the already-extensive list of illnesses being attributed to the drug. Just a few months ago, the FDA warned the public...
Continue Reading2020 — In 2020, Emery Pharma petitioned the FDA stating that studies found ranitidine molecules to be heat unstable, which was causing the creation of an unsafe amount of NDMA. Reference: “Zantac Lawsuit Leads for Attorneys: Drug Injury.” Broughton Partners, 12 Jan. 2021, https://www.broughtonpartners.com/products/zantac-lawsuit-campaigns-for-attorneys/
Continue Reading